Targeted Therapies for the Systemic Treatment of Advanced Hepatocellular Carcinoma

Author(s): F Chionh | A Azad | J Cebon
Volume: 2
Issue: 1
Year: 2010

Coagulation Disorders in Women with Idiopathic Menorrhagia

Author(s): Mehran Karimi | Abdolreza Afrasiabi | Sedighe Amoei | Jale Zolghadri | Shiva Nasirabadi | Mohammadreza Bordbar | Flora Peyvndi
Volume: 2
Issue: 1
Year: 2010

Importance of a Dental Approach in Head and Neck Cancer Therapy

Author(s): Hülya Çankaya | Pelin Güneri
Volume: 2
Issue: 1
Year: 2010

The Laboratory Assessment of KRAS Mutation Status in Colorectal Cancer

Author(s): Christos S Karapetis | Lesley E Snell
Volume: 2
Issue: 1
Year: 2010

Low Incidence of Venous Thromboembolism in Asian Myeloma Patients Treated with Thalidomide plus Dexamethasone

Author(s): Victor Bong-hang Shyu | Po-Nan Wang | Pao-Hsien Chu
Volume: 2
Issue: 1
Year: 2010

Response to Bortezomib in Refractory/Relapsed Multiple Myeloma Patients: A Single Center Experience with Discussion on Specific Issues

Author(s): M-C Kyrtsonis | D Maltezas | E Koulieris | C Zaroulis | T Tzenou | S Sachanas | V Bartzis | G Georgiou | M Dimou | S Siakavellas | T P Vassilakopoulos | M K Angelopoulou | E Koutra | A Mouzaki | G A Pangalis | P Panayiotidis
Volume: 2
Issue: 1
Year: 2010

Risk of Venous Thromboembolism in Patients receiving Systemic Therapy for Early Breast Cancer

Author(s): Julia Hoy | Alison Davis
Volume: 2
Issue: 1
Year: 2010

Venous Thromboembolism in Cancer Patients under Palliative Care: Retrospective Study and Lessons for the Future

Author(s): Thierry Merminod | Gilbert B Zulian
Volume: 2
Issue: 1
Year: 2010

Lenalidomide in Patients with Multiple Myeloma who have Received One Prior Therapy

Author(s): Monique Hartley | Rachid Baz
Volume: 2
Issue: 1
Year: 2010

Approaching Locally Advanced, Metastatic, or Recurrent Endometrial Cancer: Exploring Ixabepilone as a Therapeutic Option

Author(s): Nada M Kawar | Don S Dizon
Volume: 2
Issue: 1
Year: 2010

Comprehensive Meta-Analysis of Survival Outcomes from Two Randomized Multicenter Trials in First-Line Advanced Non-Small Cell Lung Cancer in Patients Treated with the Novel Investigational Antitumor-enhancing and Chemoprotective Agent Tavocept

Author(s): Frederick Hausheer | Stacey Bain | Michael Perry | Lingu Du | Yasuo Ohashi | Yutaka Ariyoshi | Masahiro Fukuoka
Volume: 2
Issue: 1
Year: 2010

Autoimmune Thrombocytopenic Purpura in Acute Hepatitis A—A Report and Review of Literature

Author(s): Wesley Jose | Kishore Kumar | Athira Unnikrishnan | M Palaniappan | Anoop Nair | K Pavithran
Volume: 2
Issue: 1
Year: 2010

Predictive Models of Survival in Patients with Advanced Cancer

Author(s): Eman Al Duhaiby | Jocelyn Pang | Sheldon Kwok | Edward Chow
Volume: 2
Issue: 1
Year: 2010

Immunoglobulin Heavy Chain Variable Region Mutational Status: Principle and Applications of a Clinically Available Assay

Author(s): David R. Czuchlewski | James M. Gale | Mohammad A. Vasef
Volume: 2
Issue: 1
Year: 2010

Prognostic Effect of Pathologic Fracture in Localized Osteosarcoma

Author(s): Dae-Geun Jeon
Volume: 2
Issue: 1
Year: 2010

Recent Advances in Chemotherapy for Advanced Gastric Cancer

Author(s): Yoon-Koo Kang | Dok Hyun Yoon | Baek-Yeol Ryoo | Min-Hee Ryu
Volume: 2
Issue: 1
Year: 2010

Predictive Value of D-Dimer Test, Persistent Residual Venous Thrombosis, and Thrombophilia for Venous Thromboembolism Recurrence

Author(s): Luca Spiezia | Paolo Prandoni
Volume: 2
Issue: 1
Year: 2010

Intensity-Modulated Radiation Therapy with or without Chemotherapy for Nasopharyngeal Carcinoma: A Clinical Review

Author(s): Nicola Caria | Jeremy Setton | Edward Shin | Nancy Lee
Volume: 2
Issue: 1
Year: 2010